Market Research Logo

Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018

Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018

Summary


GlobalData's Medical Devices sector report, “Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018 provides an overview of Transdermal Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transdermal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


GDME0529EPD_Sample.pdf

  • Introduction
    • Transdermal Drug Delivery Overview
  • Products under Development
    • Transdermal Drug Delivery - Pipeline Products by Stage of Development
      • Table Figure 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
      • Table Transdermal Drug Delivery - Pipeline Products by Stage of Development
    • Transdermal Drug Delivery - Pipeline Products by Segment
      • Table Figure 2: Transdermal Drug Delivery - Pipeline Products by Segment
      • Table Transdermal Drug Delivery - Pipeline Products by Segment
    • Transdermal Drug Delivery - Pipeline Products by Territory
      • Table Figure 3: Transdermal Drug Delivery - Pipeline Products by Territory
      • Table Transdermal Drug Delivery - Pipeline Products by Territory
    • Transdermal Drug Delivery - Pipeline Products by Regulatory Path
      • Table Figure 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
      • Table Transdermal Drug Delivery - Pipeline Products by Regulatory Path
    • Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
    • Transdermal Drug Delivery - Ongoing Clinical Trials
      • Table Figure 6: Transdermal Drug Delivery - Ongoing Clinical Trials
      • Table Transdermal Drug Delivery - Ongoing Clinical Trials
  • Transdermal Drug Delivery - Pipeline Products under Development by Companies
    • Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
      • Table Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
    • Transdermal Drug Delivery - Pipeline Products by Stage of Development
      • Table Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Transdermal Drug Delivery Companies and Product Overview
    • 4P Therapeutics LLC Company Overview
      • 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Passive Transdermal Clonidine Patch - Product Status
        • Table Passive Transdermal Clonidine Patch - Product Description
        • Table Passive Transdermal Fentanyl Patch - Product Status
        • Table Passive Transdermal Fentanyl Patch - Product Description
        • Table Passive Transdermal Lidocaine Patch - Product Status
        • Table Passive Transdermal Lidocaine Patch - Product Description
        • Table Passive Transdermal Patch - Product Status
        • Table Passive Transdermal Patch - Product Description
        • Table Passive Transdermal Scopalamine Patch - Product Status
        • Table Passive Transdermal Scopalamine Patch - Product Description
        • Table Transdermal Apomorphine Patch - Product Status
        • Table Transdermal Apomorphine Patch - Product Description
        • Table Transdermal Exenatide Patch - Product Status
        • Table Transdermal Exenatide Patch - Product Description
        • Table Transdermal FSH Patch - Product Status
        • Table Transdermal FSH Patch - Product Description
        • Table Transdermal Patch - Diabetes - Product Status
        • Table Transdermal Patch - Diabetes - Product Description
    • Actuated Medical Inc Company Overview
      • Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GentleDispense System - Product Status
        • Table GentleDispense System - Product Description
    • Aequus Pharmaceuticals Inc Company Overview
      • Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AQS1301 - Product Status
        • Table AQS1301 - Product Description
        • Table AQS1302 - Product Status
        • Table AQS1302 - Product Description
        • Table AQS1303 - Product Status
        • Table AQS1303 - Product Description
        • Table AQS1304 - Product Status
        • Table AQS1304 - Product Description
        • Table Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
    • Agile Therapeutics Inc Company Overview
      • Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AG200-ER Patch - Product Status
        • Table AG200-ER Patch - Product Description
        • Table AG200-SP Patch - Product Status
        • Table AG200-SP Patch - Product Description
        • Table AG890 Patch - Product Status
        • Table AG890 Patch - Product Description
        • Table Twirla (AG200-15) - Product Status
        • Table Twirla (AG200-15) - Product Description
    • Allergan Plc Company Overview
      • Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotechnology-Based Transdermal Delivery System - Product Status
        • Table Nanotechnology-Based Transdermal Delivery System - Product Description
        • Table Norethindrone Transdermal Delivery System - Product Status
        • Table Norethindrone Transdermal Delivery System - Product Description
    • Alliqua BioMedical Inc Company Overview
      • Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PHN Patch - Product Status
        • Table PHN Patch - Product Description
    • Altea Therapeutics Corporation (Inactive) Company Overview
      • Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Enoxaparin Sodium Patch - Product Status
        • Table Transdermal Enoxaparin Sodium Patch - Product Description
        • Table Transdermal Fentanyl Citrate Patch - Product Status
        • Table Transdermal Fentanyl Citrate Patch - Product Description
        • Table Transdermal Protein Patch - Product Status
        • Table Transdermal Protein Patch - Product Description
    • AMW GmbH Company Overview
      • AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anastrozole Transdermal Patch - Product Status
        • Table Anastrozole Transdermal Patch - Product Description
        • Table Rotigotine Patch - Product Status
        • Table Rotigotine Patch - Product Description
    • AngioSoma Inc Company Overview
      • AngioSoma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioSoma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal PGE-1 Patch - Product Status
        • Table Transdermal PGE-1 Patch - Product Description
    • Apogee Technology Inc Company Overview
      • Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PyraDerm - Product Status
        • Table PyraDerm - Product Description
    • Apricus Biosciences Inc Company Overview
      • Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Second Generation Vitaros Room Temperature Device - Product Status
        • Table Second Generation Vitaros Room Temperature Device - Product Description
        • Table Vitaros - Product Status
        • Table Vitaros - Product Description
    • Asahi Kasei Pharma Corp Company Overview
      • Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teribone Microneedle Patch System - Product Status
        • Table Teribone Microneedle Patch System - Product Description
    • AstraZeneca Plc Company Overview
      • AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EMLA Patch - Product Status
        • Table EMLA Patch - Product Description
        • Table AstraZeneca Plc - Ongoing Clinical Trials Overview
        • Table EMLA Patch - Peripheral Intravenous Cannulation in Children with Difficult Vein Access: Randomized Study Comparing Accuvein 400 versus Standard Care
    • Avro Life Sciences Company Overview
      • Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery Patch - Product Status
        • Table Transdermal Drug Delivery Patch - Product Description
    • Burke Pharmaceuticals LLC Company Overview
      • Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BLU402 Hydrogel Patch Wart Kit - Product Status
        • Table BLU402 Hydrogel Patch Wart Kit - Product Description
        • Table Drug Delivery Patch - Product Status
        • Table Drug Delivery Patch - Product Description
    • CB Scientific Inc. Company Overview
      • CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pain-Patch - Product Status
        • Table Pain-Patch - Product Description
    • Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
      • Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Topical Diclofenac Patch - Product Status
        • Table Topical Diclofenac Patch - Product Description
    • Chrono Therapeutics Inc Company Overview
      • Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biologically-Timed Drug Delivery Device - Product Status
        • Table Biologically-Timed Drug Delivery Device - Product Description
    • Corium International Inc Company Overview
      • Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corplex Donepezil Transdermal System - Product Status
        • Table Corplex Donepezil Transdermal System - Product Description
        • Table Corplex Memantine Transdermal System - Product Status
        • Table Corplex Memantine Transdermal System - Product Description
        • Table Corplex Ropinirole Transdermal System - Product Status
        • Table Corplex Ropinirole Transdermal System - Product Description
        • Table MicroCor Transdermal System - Product Status
        • Table MicroCor Transdermal System - Product Description
        • Table MicroCor Zolmitriptan System - Product Status
        • Table MicroCor Zolmitriptan System - Product Description
        • Table MicroJet - Product Status
        • Table MicroJet - Product Description
        • Table Corium International Inc - Ongoing Clinical Trials Overview
        • Table Corplex Donepezil Transdermal System - A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex 10mg Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept
        • Table Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease
    • DBV Technologies SA Company Overview
      • DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viaskin Peanut - Product Status
        • Table Viaskin Peanut - Product Description
        • Table DBV Technologies SA - Ongoing Clinical Trials Overview
        • Table Viaskin Peanut - A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
        • Table Viaskin Peanut - Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
        • Table Viaskin Peanut - Safety Study of Viaskin Peanut to Treat Peanut Allergy: REALISE
    • DD Therapeutics LLC Company Overview
      • DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Delivery System - Product Status
        • Table Transdermal Delivery System - Product Description
    • Dermisonics Inc (Inactive) Company Overview
      • Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table U-Strip - Product Status
        • Table U-Strip - Product Description
    • Dharma Therapeutics, Inc. (Inactive) Company Overview
      • Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iontophoretic Drug Delivery Patch - Product Status
        • Table Iontophoretic Drug Delivery Patch - Product Description
    • Drexel University Company Overview
      • Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasonically Assisted Transcutaneous Drug Delivery Device - Product Status
        • Table Ultrasonically Assisted Transcutaneous Drug Delivery Device - Product Description
    • DURECT Corp Company Overview
      • DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eladur - Product Status
        • Table Eladur - Product Description
    • Echo Therapeutics Inc Company Overview
      • Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prelude SkinPrep System - Product Status
        • Table Prelude SkinPrep System - Product Description
    • Emplicure AB Company Overview
      • Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro-needle Patch - Product Status
        • Table Micro-needle Patch - Product Description
        • Table Tamper Resistant Patch - Product Status
        • Table Tamper Resistant Patch - Product Description
    • Endo International Plc Company Overview
      • Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rivastigmine Patch - Product Status
        • Table Rivastigmine Patch - Product Description
    • Extend Biosciences Inc Company Overview
      • Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-Invasive Needle-Free Skin Patch - Product Status
        • Table Non-Invasive Needle-Free Skin Patch - Product Description
    • EyeGate Pharmaceuticals Inc Company Overview
      • EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate II Delivery System - Product Status
        • Table EyeGate II Delivery System - Product Description
        • Table EyeGate Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table EyeGate II Delivery System - A Prospective, Multi-center, Randomized, Double-masked, Positive Controlled, Phase III Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-infectious Anterior Segment Uveitis
        • Table EyeGate II Delivery System - Multi-center, Double-masked, Randomized, Placebo-controlled Phase IIb Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Having Undergone Cataract Surgery with Implantation of a Posterior Chamber Intraocular Lens (IOL)
    • Fe3 Medical Inc Company Overview
      • Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iron Supplement Patch - Product Status
        • Table Iron Supplement Patch - Product Description
    • Hisamitsu Pharmaceutical Co Inc Company Overview
      • Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fentos Tape - Product Status
        • Table Fentos Tape - Product Description
        • Table HP-1010 Adhesive Skin Patch - Product Status
        • Table HP-1010 Adhesive Skin Patch - Product Description
        • Table HP-1030 Adhesive Skin Patch - Product Status
        • Table HP-1030 Adhesive Skin Patch - Product Description
        • Table HP-3000 Adhesive Skin Patch - Product Status
        • Table HP-3000 Adhesive Skin Patch - Product Description
        • Table HP-3070 Adhesive Skin Patch - Product Status
        • Table HP-3070 Adhesive Skin Patch - Product Description
        • Table HP-3150 Adhesive Skin Patch - Product Status
        • Table HP-3150 Adhesive Skin Patch - Product Description
        • Table HP-5000 Adhesive Skin Patch - Product Status
        • Table HP-5000 Adhesive Skin Patch - Product Description
        • Table HTU-520 Patch - Product Status
        • Table HTU-520 Patch - Product Description
        • Table Hisamitsu Pharmaceutical Co Inc - Ongoing Clinical Trials Overview
        • Table HP-3070 Adhesive Skin Patch - A Randomized, Double-blind, Placebo-controlled, Fixed-dose, 6- week, In-patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed with Schizophrenia
    • ImmuPatch Company Overview
      • ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview
        • Table ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coated ImmuPatch - Product Status
        • Table Coated ImmuPatch - Product Description
        • Table Dissolvable ImmuPatch - Product Status
        • Table Dissolvable ImmuPatch - Product Description
    • Indian Institute of Science Company Overview
      • Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Patch - Product Status
        • Table Drug Delivery Patch - Product Description
    • Indian Institute of Technology Bombay Company Overview
      • Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
        • Table Poly (n-Vinyl Caprolactam) Based Patch - Product Status
        • Table Poly (n-Vinyl Caprolactam) Based Patch - Product Description
    • InMed Pharmaceuticals Inc Company Overview
      • InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table INM-750 - Drug Delivery Device - Product Status
        • Table INM-750 - Drug Delivery Device - Product Description
    • Institute of Materials Research & Engineering Company Overview
      • Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview
        • Table Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skin Breaching Device - Product Status
        • Table Skin Breaching Device - Product Description
    • Intercell AG (Inactive) Company Overview
      • Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Travelers Diarrhea Vaccine Patch - Product Status
        • Table Travelers Diarrhea Vaccine Patch - Product Description
    • Interstitial NS Company Overview
      • Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoMAP - Product Status
        • Table NanoMAP - Product Description
    • Isis Biopolymer, Inc. Company Overview
      • Isis Biopolymer, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Isis Biopolymer, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gentle Touch - Product Status
        • Table Gentle Touch - Product Description
        • Table IsisIQ CLI - Product Status
        • Table IsisIQ CLI - Product Description
        • Table Isis Biopolymer, Inc. - Ongoing Clinical Trials Overview
        • Table Gentle Touch - Laser Hair Reduction by Combined Bipolar RF and 755 nm Laser Energies
    • Janisys Company Overview
      • Janisys Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janisys Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janisys Drug Delivery System - Product Status
        • Table Janisys Drug Delivery System - Product Description
    • KTH Royal Institute of Technology Company Overview
      • KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedles Based Skin Patch - Product Status
        • Table Microneedles Based Skin Patch - Product Description
    • Kyowa Hakko Kirin Co Ltd Company Overview
      • Kyowa Hakko Kirin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kyowa Hakko Kirin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sancuso Patch - Product Status
        • Table Sancuso Patch - Product Description
    • Lohmann Therapie-Systeme AG Company Overview
      • Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Patch - Product Status
        • Table Smart Patch - Product Description
    • Massachusetts Institute of Technology Company Overview
      • Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table mPill - Product Status
        • Table mPill - Product Description
    • Mayne Pharma Group Ltd Company Overview
      • Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Motion Sickness Transdermal Delivery System Patch - Product Status
        • Table Motion Sickness Transdermal Delivery System Patch - Product Description
    • Medherant Ltd Company Overview
      • Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ibuprofen TEPI Patch - Product Status
        • Table Ibuprofen TEPI Patch - Product Description
        • Table Lidocaine TEPI Patch - Product Status
        • Table Lidocaine TEPI Patch - Product Description
        • Table Methyl Salicylate TEPI Patch - Product Status
        • Table Methyl Salicylate TEPI Patch - Product Description
    • MEDRx Co Ltd Company Overview
      • MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Etoreat - Product Status
        • Table Etoreat - Product Description
        • Table MRX-1OXT Patch - Product Status
        • Table MRX-1OXT Patch - Product Description
        • Table MRX-4TZT Patch - Product Status
        • Table MRX-4TZT Patch - Product Description
        • Table MRX-5DML Patch - Product Status
        • Table MRX-5DML Patch - Product Description
        • Table MRX-5LBT Patch - Product Status
        • Table MRX-5LBT Patch - Product Description
        • Table MRX-7LAT Lidocaine Patch - Product Status
        • Table MRX-7LAT Lidocaine Patch - Product Description
    • MedRx, Inc. Company Overview
      • MedRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MedRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Array - Product Status
        • Table Microneedle Array - Product Description
    • Microdermics Inc Company Overview
      • Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Drug Delivery System - Product Status
        • Table Microneedle Drug Delivery System - Product Description
    • Micron Biomedical Inc Company Overview
      • Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Patch - Flu - Product Status
        • Table Microneedle Patch - Flu - Product Description
    • Micropoint Technologies Pte Ltd Company Overview
      • Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-coated Micropoint Patch - Product Status
        • Table Drug-coated Micropoint Patch - Product Description
    • Nemaura Pharma Ltd Company Overview
      • Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Memspatch - Product Status
        • Table Memspatch - Product Description
        • Table Micropatch - Product Status
        • Table Micropatch - Product Description
        • Table Mycrolator - Product Status
        • Table Mycrolator - Product Description
        • Table Transdermal Patch - Alzheimer's Disease - Product Status
        • Table Transdermal Patch - Alzheimer's Disease - Product Description
        • Table Transdermal Patch - Hypertension - Product Status
        • Table Transdermal Patch - Hypertension - Product Description
        • Table Transdermal Patch - Parkinson's Disease - Product Status
        • Table Transdermal Patch - Parkinson's Disease - Product Description
    • NeuroDerm Ltd Company Overview
      • NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ND0601 Dermal Patch - Product Status
        • Table ND0601 Dermal Patch - Product Description
        • Table ND0611 Dermal Patch - Product Status
        • Table ND0611 Dermal Patch - Product Description
        • Table ND0901 - Product Status
        • Table ND0901 - Product Description
    • Nitto Denko Corp Company Overview
      • Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PassPort Exenatide Transdermal Delivery System - Product Status
        • Table PassPort Exenatide Transdermal Delivery System - Product Description
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Description
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody Delivery Microneedle Patch - Product Status
        • Table Antibody Delivery Microneedle Patch - Product Description
        • Table Intraconazole Microneedles - Product Status
        • Table Intraconazole Microneedles - Product Description
        • Table Skin Patch - Melanoma - Product Status
        • Table Skin Patch - Melanoma - Product Description
    • Noven Pharmaceuticals Inc Company Overview
      • Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ATS Adhesive Skin Patch - Product Status
        • Table ATS Adhesive Skin Patch - Product Description
        • Table Lidocaine Topical Patch - Product Status
        • Table Lidocaine Topical Patch - Product Description
    • NutriBand Inc Company Overview
      • NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TD00A1 - Transdermal Drug Delivery System - Product Status
        • Table TD00A1 - Transdermal Drug Delivery System - Product Description
        • Table TD00G1 - Transdermal Drug Delivery System - Product Status
        • Table TD00G1 - Transdermal Drug Delivery System - Product Description
        • Table TD0CD1/TD0CD2 - Transdermal Drug Delivery System - Product Status
        • Table TD0CD1/TD0CD2 - Transdermal Drug Delivery System - Product Description
        • Table TD0ID1 - Transdermal Drug Delivery System - Product Status
        • Table TD0ID1 - Transdermal Drug Delivery System - Product Description
        • Table TD0IJD - Transdermal Drug Delivery System - Product Status
        • Table TD0IJD - Transdermal Drug Delivery System - Product Description
    • Nuvo Pharmaceuticals Inc Company Overview
      • Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alprazolam Patch - Product Status
        • Table Alprazolam Patch - Product Description
    • Pain Therapeutics Inc Company Overview
      • Pain Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pain Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FENROCK - Product Status
        • Table FENROCK - Product Description
    • Phosphagenics Ltd Company Overview
      • Phosphagenics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phosphagenics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TPM - Diclofenac - Product Status
        • Table TPM - Diclofenac - Product Description
        • Table TPM - Lidocaine - Product Status
        • Table TPM - Lidocaine - Product Description
        • Table TPM-Oxycodone Patch - Product Status
        • Table TPM-Oxycodone Patch - Product Description
        • Table TPM-Oxymorphone Patch - Product Status
        • Table TPM-Oxymorphone Patch - Product Description
        • Table Phosphagenics Ltd - Ongoing Clinical Trials Overview
        • Table TPM-Oxycodone Patch - Oxycodone Patch Dosing in Phase 2 Clinical Trial
    • Prometheon Pharma LLC Company Overview
      • Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table HeatWave Patch - Product Status
        • Table HeatWave Patch - Product Description
        • Table TruePatch - Basal Insulin - Product Status
        • Table TruePatch - Basal Insulin - Product Description
        • Table TruePatch - Rapid-Acting (Bolus) Insulin - Product Status
        • Table TruePatch - Rapid-Acting (Bolus) Insulin - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pump For Drug-Delivery Patch - Product Status
        • Table Pump For Drug-Delivery Patch - Product Description
    • Radius Health Inc Company Overview
      • Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tymlos Patch - Product Status
        • Table Tymlos Patch - Product Description
    • Scilex Ltd Company Overview
      • Scilex Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scilex Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table D2T Patch - Acute Pain - Product Status
        • Table D2T Patch - Acute Pain - Product Description
        • Table ZTlido - Product Status
        • Table ZTlido - Product Description
    • Skinject Inc Company Overview
      • Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SkinJect PatchIT - Product Status
        • Table SkinJect PatchIT - Product Description
    • Sparsha Pharma International Pvt Ltd Company Overview
      • Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5-HT3 Receptor Antagonist Patch - Product Status
        • Table 5-HT3 Receptor Antagonist Patch - Product Description
        • Table Tulobuterol Patch - Product Status
        • Table Tulobuterol Patch - Product Description
    • Sparsha Pharma USA Inc Company Overview
      • Sparsha Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sparsha Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fen-Touch - Product Status
        • Table Fen-Touch - Product Description
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro Needle Patch - Product Status
        • Table Micro Needle Patch - Product Description
    • Stanford University Company Overview
      • Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dissolving Microneedles - Product Status
        • Table Dissolving Microneedles - Product Description
    • Sumitomo Dainippon Pharma Co Ltd Company Overview
      • Sumitomo Dainippon Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sumitomo Dainippon Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LONASEN Patch - Product Status
        • Table LONASEN Patch - Product Description
        • Table Sumitomo Dainippon Pharma Co Ltd - Ongoing Clinical Trials Overview
        • Table LONASEN Patch - Confirmatory Study of DSP-5423P in Patients with Schizophrenia
    • Syntropharma Ltd Company Overview
      • Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nalsyn - Product Status
        • Table Nalsyn - Product Description
        • Table Selsyn Patch - Product Status
        • Table Selsyn Patch - Product Description
    • Taho Pharmaceuticals Ltd Company Overview
      • Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAH6601 Patch - Product Status
        • Table TAH6601 Patch - Product Description
        • Table TAH7702 Patch - Product Status
        • Table TAH7702 Patch - Product Description
        • Table TAH8801 Patch - Product Status
        • Table TAH8801 Patch - Product Description
        • Table TAH9901 Patch - Product Status
        • Table TAH9901 Patch - Product Description
    • Teikoku Pharma USA Inc Company Overview
      • Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 7-Day Rivastigmine Patch - Product Status
        • Table 7-Day Rivastigmine Patch - Product Description
        • Table TPU-002 - Product Status
        • Table TPU-002 - Product Description
        • Table TPU-006 - Product Status
        • Table TPU-006 - Product Description
        • Table TPU-010 - Product Status
        • Table TPU-010 - Product Description
        • Table TPU-012 - Product Status
        • Table TPU-012 - Product Description
    • tesa Labtec GmbH Company Overview
      • tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table LabiPatch - Cold Sores - Product Status
        • Table LabiPatch - Cold Sores - Product Description
        • Table Ropivacaine Transdermal Patch - Product Status
        • Table Ropivacaine Transdermal Patch - Product Description
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Patch - Product Status
        • Table Drug Delivery Patch - Product Description
    • The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
      • The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanoliposomal Transdermal Drug Delivery System - Product Status
        • Table Nanoliposomal Transdermal Drug Delivery System - Product Description
    • TheraJect Inc Company Overview
      • TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DrugMAT - Product Status
        • Table DrugMAT - Product Description
        • Table VaxMAT - Product Status
        • Table VaxMAT - Product Description
    • TheraSolve NV Company Overview
      • TheraSolve NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraSolve NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table MemoPatch - Product Status
        • Table MemoPatch - Product Description
    • Theratech, Inc. Company Overview
      • Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ChemoPatch - Product Status
        • Table ChemoPatch - Product Description
    • Titan Pharmaceuticals Inc Company Overview
      • Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Probuphine Subdermal Implant - Product Status
        • Table Probuphine Subdermal Implant - Product Description
        • Table Ropinirole Implant - Product Status
        • Table Ropinirole Implant - Product Description
        • Table Titan Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table Ropinirole Implant - An Open-label, Relative Bioavailability Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ropinirole Implants in Patients with Parkinson's Disease Switched from Oral Immediate-release Ropinirole While on L-Dopa
    • Transcu Group Limited (Inactive) Company Overview
      • Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery System - Product Status
        • Table Transdermal Drug Delivery System - Product Description
    • Transdermal Delivery Solutions Corp Company Overview
      • Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Testagen HypoSpray - Product Status
        • Table Testagen HypoSpray - Product Description
        • Table Transdermal Delivery Solutions Corp - Ongoing Clinical Trials Overview
        • Table Testagen HypoSpray - A Multiple-dose, Single Period, Phase II Dose Ranging Study to Examine Testagen TDS-Testosterone 5% in Adult Male Subjects
        • Table Testagen HypoSpray - A Single-dose, Single Period, Phase II Pharmacokinetic Study to Examine Testagen TDS-testosterone for Its Potential to be Inadvertently Transferred by Skin Contact after Dosing in Healthy Adult Subjects
    • Transdermal Specialties, Inc. Company Overview
      • Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table U-Strip Insulin Patch - Product Status
        • Table U-Strip Insulin Patch - Product Description
    • TransPharma Medical Ltd (Inactive) Company Overview
      • TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ViaDor - hPTH - Product Status
        • Table ViaDor - hPTH - Product Description
        • Table ViaDor-hGH - Product Status
        • Table ViaDor-hGH - Product Description
    • Transport Pharmaceuticals Inc Company Overview
      • Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SoloVir Electrokinetic Transdermal System - Product Status
        • Table SoloVir Electrokinetic Transdermal System - Product Description
    • TSRL Inc Company Overview
      • TSRL Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TSRL Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Patch - Product Status
        • Table Microneedle Patch - Product Description
    • Univec, Inc. (Inactive) Company Overview
      • Univec, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Univec, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nicotine Replacement Patch - Product Status
        • Table Nicotine Replacement Patch - Product Description
        • Table Univec, Inc. (Inactive) - Ongoing Clinical Trials Overview
        • Table Nicotine Replacement Patch - Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
    • University of Illinois at Chicago Company Overview
      • University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery System - Breast Cancer - Product Status
        • Table Transdermal Drug Delivery System - Breast Cancer - Product Description
    • University of North Carolina at Chapel Hill Company Overview
      • University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
        • Table SCHIELD - Product Status
        • Table SCHIELD - Product Description
    • University of North Carolina at Chapel Hill School of Medicine Company Overview
      • University of North Carolina at Chapel Hill School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Carolina at Chapel Hill School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skin Patch - Product Status
        • Table Skin Patch - Product Description
    • University of Toronto Company Overview
      • University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Transdermal Patch - Hypoglycemia - Product Status
        • Table Microneedle Transdermal Patch - Hypoglycemia - Product Description
    • ViiV Healthcare UK Ltd Company Overview
      • ViiV Healthcare UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ViiV Healthcare UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microarray Patch - HIV - Product Status
        • Table Microarray Patch - HIV - Product Description
    • Vyteris, Inc. (Inactive) Company Overview
      • Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Patch Iontophoretic Drug Delivery - Product Status
        • Table Smart Patch Iontophoretic Drug Delivery - Product Description
    • Xel Pharmaceuticals Inc Company Overview
      • Xel Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xel Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table XEL 001HP - Product Status
        • Table XEL 001HP - Product Description
        • Table XEL 002BP - Product Status
        • Table XEL 002BP - Product Description
        • Table XEL 003FL - Product Status
        • Table XEL 003FL - Product Description
        • Table XEL 004FP - Product Status
        • Table XEL 004FP - Product Description
        • Table XEL 005OP - Product Status
        • Table XEL 005OP - Product Description
    • Zambon Italia Srl Company Overview
      • Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZP-024 - Product Status
        • Table ZP-024 - Product Description
    • Z-Cube Srl Company Overview
      • Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Embedded Carbon Nanotube Skin Patch - Product Status
        • Table Embedded Carbon Nanotube Skin Patch - Product Description
    • Zosano Pharma Corp Company Overview
      • Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table M207 Patch - Product Status
        • Table M207 Patch - Product Description
    • Zynerba Pharmaceuticals Inc Company Overview
      • Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZYN001 - THC Pro-Drug Patch - Product Status
        • Table ZYN001 - THC Pro-Drug Patch - Product Description
        • Table Zynerba Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Bio-equivalence Study of ZYN-001 in Healthy Volunteers
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Multiple Rising Study of ZYN-001
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Single and Multiple Rising Dose Study of ZYN-001 in Healthy Subjects
        • Table ZYN001 - THC Pro-Drug Patch - Phase IIa Study of ZYN-001 in Subjects with Fibromyalgia
        • Table ZYN001 - THC Pro-Drug Patch - Phase IIa Study of ZYN-001 in Subjects with Peripheral Neuropathic Pain
  • Transdermal Drug Delivery- Recent Developments
    • Mar 12, 2018: Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS (abaloparatide) Injection
    • Mar 12, 2018: Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
    • Mar 12, 2018: Zosano Pharma Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Operational Update
    • Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology
    • Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
    • Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus' Anti- Nausea Patch
    • Mar 05, 2018: 3M Announces New Leadership Appointments
    • Mar 02, 2018: Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine
    • Mar 02, 2018: EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
    • Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs
    • Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer
    • Feb 28, 2018: Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for PHN Pain
    • Feb 28, 2018: Revance Announces Fourth Quarter and Full Year 2017 Financial Results
    • Feb 28, 2018: Syneos Health Reports Fourth Quarter and Full Year 2017 Results
    • Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement
    • Feb 28, 2018: Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care
    • Feb 27, 2018: Hisamitsu Pharmaceutical Announces the Results of Phase III Clinical Study of HP-3000 in Japan
    • Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors
    • Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified
    • Feb 23, 2018: Sumitomo Dainippon Pharma Names Hiroshi Nomura As President And CEO
    • Feb 22, 2018: UCB Full Year Report 2017
    • Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
    • Feb 15, 2018: Camurus: Full year report 2017
    • Feb 14, 2018: Sumitomo Dainippon Pharma and Nitto Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN
    • Feb 14, 2018: DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut
    • Feb 13, 2018: Naltrexone transdermal patch (Nalsyn) has patent granted in USA
    • Feb 08, 2018: Teva Reports 2017 Full Year and Fourth Quarter Financial Results
    • Feb 08, 2018: Syneos Health Names Lisa van Capelle Chief Human Resources Officer
    • Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
    • Feb 08, 2018: Syneos Health Names Lisa van Capelle Chief Human Resources Officer
    • Feb 07, 2018: Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings
    • Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017
    • Feb 06, 2018: Teva Pharmaceuticals laid off 46 employees in Parsippany
    • Feb 05, 2018: EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
    • Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer
    • Feb 01, 2018: Japanese Pharmaceutical Company Agrees to 20 Year Settlement Agreement after Attempting to Block Generics
    • Feb 01, 2018: Chrono Therapeutics Announces Appointment of David Happel as Chief Executive Officer
    • Feb 01, 2018: Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian
    • Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti- Nausea Patch
    • Jan 31, 2018: Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.
    • Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance
    • Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
    • Jan 27, 2018: Prometheon Pharma Completes Pilot Study of Insulin Patch in Mini-Pigs
    • Jan 25, 2018: 3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook
    • Jan 24, 2018: Solasia Pharma Announces Head Office Relocation
    • Jan 19, 2018: Hisamitsu Pharmaceutical received Japan regulatory approval for ALLESAGA TAPE (HP-3060) , a transdermal system for the treatment of allergic rhinitis
    • Jan 19, 2018: Teva Layoffs To Affect 65 Employees In Horsham, North Wales
    • Jan 18, 2018: Lannett Appoints Timothy C. Crew As Board Of Directors
    • Jan 09, 2018: Valeritas Appoints Joseph Saldanha as Chief Business Officer
    • Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice
    • Jan 08, 2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference
    • Jan 04, 2018: EyeGate Promotes Sarah Romano to Chief Financial Officer
    • Jan 04, 2018: Generex CEO Provides 2017 Year-End Summary to Stakeholders
    • Jan 03, 2018: Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate Update
    • Dec 28, 2017: Luye Pharma Group: Announcement Progress of Patent Litigation in Relation to Rivastigmine 1 Day Patch
    • Dec 22, 2017: Agile Therapeutics Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
    • Dec 19, 2017: EyeGate Awarded New U.S. Patent for Iontophoretic Delivery of Corticosteroids to the Eye
    • Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
    • Dec 18, 2017: EyeGate Achieves 75% Enrollment in Pivotal Phase III Clinical Trial for Anterior Uveitis Triggering Milestone Payment
    • Dec 18, 2017: Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
    • Dec 15, 2017: Zosano Announces Resignation of Bruce Steel from Board of Directors
    • Dec 14, 2017: Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance
    • Dec 13, 2017: Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020
    • Dec 13, 2017: Dr Alberto Martinez appointed President and CEO of Mundipharma International
    • Dec 11, 2017: Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
    • Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights
    • Nov 27, 2017: European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine
    • Nov 27, 2017: Teva Announces New Organization Structure and Leadership Changes
    • Nov 22, 2017: Nuvo Pharmaceuticals Announces Appointment of Jesse Ledger as President & Chief Executive Officer
    • Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
    • Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients
    • Nov 17, 2017: Medherant wins Excellence in Science & Technology Award
    • Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
    • Nov 16, 2017: Premier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-President
    • Nov 15, 2017: Heiko Schipper is the new CEO and Head of the Consumer Health Division at Bayer
    • Nov 14, 2017: Scilex Pharmaceuticals, Sorrento Therapeutics' Subsidiary, Files Marketing Authorization Application In The European Union For ZTlido
    • Nov 14, 2017: Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer)
    • Nov 13, 2017: Lilly Appoints Philip Johnson to Senior Vice President and Treasurer
    • Nov 13, 2017: SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update
    • Nov 10, 2017: Researchers use a skin patch, infrared light, and melanin to battle melanoma
    • Nov 09, 2017: Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update
    • Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
    • Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
    • Nov 08, 2017: EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery
    • Nov 08, 2017: Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser
    • Nov 08, 2017: Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK
    • Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
    • Nov 08, 2017: Valeritas Reports Third Quarter 2017 Financial Results
    • Nov 07, 2017: Noven Files Patent Infringement Lawsuit Against Alvogen
    • Nov 07, 2017: Antares Pharma Reports Third Quarter 2017 Operating and Financial Results
    • Nov 06, 2017: Agile Therapeutics Reports Third Quarter 2017 Financial Results
    • Nov 06, 2017: Lannett Reports Solid Fiscal 2018 First-Quarter Financial Results, Significantly Increases Fiscal 2018 Guidance
    • Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
    • Nov 02, 2017: Teva Reports Third Quarter 2017 Financial Results
    • Nov 01, 2017: Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion
    • Nov 01, 2017: Nuvo Pharmaceuticals Announces 2017 Third Quarter Results
    • Nov 01, 2017: DURECT Announces Third Quarter 2017 Financial Results and Provides Corporate Update
    • Oct 31, 2017: Improved NSAID Gels with 3x Faster Penetration Rates and 48 Hour Sustained Release Developed by Nemaura Pharma
    • Oct 31, 2017: Agile Therapeutics Presents Additional Phase 3 SECURE Trial Results for Twirla at the American Society for Reproductive Medicine Scientific Congress & Expo 2017
    • Oct 30, 2017: Kare Schultz to Join Teva as President and Chief Executive Officer
    • Oct 30, 2017: GSK opens new regional headquarters for Asia in Singapore
    • Oct 26, 2017: Camurus: Interim Report January-September 2017
    • Oct 25, 2017: Axiron Net Sales, Quarter To 30 September 2017
    • Oct 25, 2017: GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER
    • Oct 25, 2017: The Medicines Company Reports Third-Quarter 2017 Business and Financial Results
    • Oct 24, 2017: Lilly Reports Third-Quarter Results 2017
    • Oct 24, 2017: 3M Delivers Record Third-Quarter Sales and Earnings per Share; Company Increases Full-Year 2017 Outlook
    • Oct 23, 2017: Eye Care Thought Leaders Join EyeGate Scientific Advisory Board
    • Oct 20, 2017: UCB First Nine Months Interim Report 2017: Strong 9 months performance allows for increase of 2017 financial outlook
    • Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs
    • Oct 17, 2017: Bayer Appoints Brenda L. Raphael Senior Vice President and General Manager of Therapeutics Business Unit for Consumer Health
    • Oct 12, 2017: DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut
    • Oct 12, 2017: SteadyMed Receives Notice of Allowance for its European Patent Relating to Enhanced Reduction of Infusion-Site Pain
    • Oct 11, 2017: First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
    • Oct 11, 2017: Transdermal Estradiol Shows Promise in Treating and Preventing Perimenopausal Depression
    • Oct 10, 2017: Agile Therapeutics Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
    • Oct 10, 2017: Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole
    • Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
    • Oct 04, 2017: Zosano Appoints Kenneth Greathouse to Board of Directors
    • Oct 02, 2017: Agile Therapeutics to Host First Analyst Day on October 10, 2017
    • Oct 02, 2017: 3M Announces New Leadership Appointments
    • Sep 29, 2017: Skin patch dissolves fat, could help treat diabetes
    • Sep 29, 2017: Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
    • Sep 28, 2017: Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting
    • Sep 27, 2017: Microneedles can increase the effectiveness of topical anesthesia used in dentistry
    • Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System
    • Sep 25, 2017: New Study Showcases Economic Impact of Allergan Operations on French Economy
    • Sep 20, 2017: DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
    • Sep 19, 2017: Teva Completes Amendment to Credit Facilities
    • Sep 19, 2017: FluGen Announces Expanded Role for Clinical Advisory Board: Dr. Robert Belshe to Chair
    • Sep 18, 2017: National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant
    • Sep 14, 2017: Intarcia and Numab Reach Key Milestone with Selection of Multi-specific Development Candidate for Autoimmune Disease
    • Sep 12, 2017: FDA Acknowledges Receipt Of Sorrento Therapeutics NDA For ZTlido; PDUFA Date Set For February 28, 2018
    • Sep 11, 2017: Teva Names Kare Schultz as President and Chief Executive Officer
    • Sep 11, 2017: The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts
    • Sep 07, 2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch
    • Sep 07, 2017: Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine
    • Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth
    • Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors
    • Sep 05, 2017: FluGen Announces C. Boyd Clarke Has Been Named Executive Chairman
    • Sep 01, 2017: Start of MRX-4TZT Phase I a' Clinical Trial in the United States
    • Aug 31, 2017: Kyowa Hakko Kirin: Announcement of submission of supplemental new drug application for the addition of a new 0.5mg dose of the transdermal, long-acting pain relief patch FENTOS TAPE
    • Aug 31, 2017: Aquavit's iMicrotox (IMX-001) Study Receives IRB Approval
    • Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
    • Aug 29, 2017: Sorrento Therapeutics Submits NDA For ZTlidoNext-Generation Lidocaine Patch
    • Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights
    • Aug 24, 2017: Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment
    • Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole
    • Aug 23, 2017: Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018
    • Aug 22, 2017: Teikoku Pharma USA Announces Positive Topline Results from Phase 2 Clinical Trial of TPU-006
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 15, 2017: New Study Results Show Over-the-Counter LidoPatch as Effective as Prescription Lidocaine Patches
    • Aug 14, 2017: Amy E. Hood Elected to 3M Board of Directors
    • Aug 11, 2017: SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
    • Aug 11, 2017: Valeritas Reports Second Quarter 2017 Financial Results
    • Aug 10, 2017: Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update
    • Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results
    • Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
    • Aug 08, 2017: DURECT Announces Second Quarter 2017 Financial Results and Provides Corporate Update
    • Aug 08, 2017: Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full- Year Financial Results, Comments On Fiscal 2018 Outlook
    • Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results
    • Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
    • Aug 03, 2017: Teva Reports Second Quarter 2017 Financial Results
    • Aug 03, 2017: Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion
    • Aug 03, 2017: Revance Releases Second Quarter 2017 Results
    • Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
    • Aug 01, 2017: EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP- 437 for Cataract Surgery
    • Jul 31, 2017: Perrigo Announces Launch Of AB Rated Generic Version Of Transderm Scop 1.5 mg
    • Jul 31, 2017: SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
    • Jul 28, 2017: Agile Therapeutics Reports Second Quarter 2017 Financial Results
    • Jul 27, 2017: Agile Therapeutics Announces FDA Acceptance Of The NDA Resubmission Of Twirla
    • Jul 27, 2017: UCB with a strong first half year 2017 - giving rise to the financial outlook for 2017
    • Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
    • Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
    • Jul 25, 2017: Lilly Reports Second-Quarter Results
    • Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook
    • Jul 23, 2017: Teva to Terminate Around 300 jobs in Israel
    • Jul 21, 2017: GSK announces Board and Committee changes
    • Jul 19, 2017: Joseph H. Boccuzi Appointed to Allergan Board of Directors
    • Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
    • Jul 18, 2017: Hisamitsu Pharmaceutical will begin clinical trial of phase III for cancer pain of HP-3150
    • Jul 17, 2017: Lannett Appoints Samuel H. Israel As General Counsel
    • Jul 13, 2017: Camurus: Interim report January-June 2017
    • Jul 13, 2017: Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
    • Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
    • Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch
    • Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.
    • Jun 29, 2017: Fortune Article Highlights Titan Pharmaceuticals And Its ProNeura Technology
    • Jun 27, 2017: Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla
    • Jun 26, 2017: Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program
    • Jun 26, 2017: Medherant expands management team with appointment of Sally Waterman, COO and Angus Hone, CFO
    • Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P.
    • Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego
    • Jun 20, 2017: Lannett Names Patrick G. LePore To Board of Directors
    • Jun 20, 2017: 3M Announces New Leadership Appointments
    • Jun 19, 2017: Patent Granted in the United States for Microneedle Array Applicators
    • Jun 19, 2017: GSK confirms start date for Luke Miels
    • Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change
    • Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch
    • Jun 14, 2017: Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces Positive Data from Head to Head Adhesion Study with its Lead Product, ZTlido
    • Jun 14, 2017: Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    • Jun 13, 2017: Braeburn and Knight Therapeutics Announce Filing of PROBUPHINE in Canada
    • Jun 06, 2017: Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary TEPI Patch
    • Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors
    • Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer
    • Jun 01, 2017: Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve Cannabinoid-Based Therapeutics
    • Jun 01, 2017: Tapemark Manufacturing Facility Completes Successful FDA Pre- Approval and General GMP Inspection
    • May 30, 2017: Patent Granted in Japan for a Transdermal Drug with Acid Scavenger
    • May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights
    • May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 18, 2017: Nemaura Pharma Memspatch Addresses Diabetics Fear of Needle Puncture Pain
    • May 15, 2017: Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer
    • May 12, 2017: SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
    • May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results
    • May 11, 2017: Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study
    • May 11, 2017: Ropivacaine transdermal patch for the treatment of neuropathic pain
    • May 11, 2017: Teva Reports First Quarter 2017 Financial Results
    • May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
    • May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications
    • May 10, 2017: DURECT Announces First Quarter 2017 Financial Results and Provides Corporate Update
    • May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results
    • May 09, 2017: Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
    • May 09, 2017: Revance Releases First Quarter 2017 Results
    • May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results
    • May 09, 2017: Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes
    • May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
    • May 08, 2017: Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer
    • May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
    • May 08, 2017: Agile Therapeutics Reports First Quarter 2017 Financial Results
    • May 08, 2017: Sumitomo Dainippon Pharma announces personnel change
    • May 06, 2017: Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla at ACOG 2017
    • May 04, 2017: Apricus Biosciences Announces the Initiation of Vitaros Drug-Device Human Factors Study
    • May 03, 2017: Camurus Announces Interim Report January-March 2017
    • May 02, 2017: Lannett Reports Fiscal 2017 Third-Quarter Financial Results
    • May 01, 2017: Radius Health Reports First Quarter 2017 Financial and Operating Results
    • May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights
    • Apr 27, 2017: Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women's Health
    • Apr 26, 2017: Axiron Net Sales, quarter to March 2017
    • Apr 26, 2017: Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer
    • Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results
    • Apr 26, 2017: GSK delivers another quarter of continued progress
    • Apr 25, 2017: Lilly Reports First-Quarter 2017 Results
    • Apr 25, 2017: 3M Delivers First-Quarter Sales of $7.7 Billion and Earnings of $2.16 per Share; Company Raises Its Full-Year 2017 Outlook
    • Apr 24, 2017: UCB First Three Months Interim Report 2017: UCB with a good start into 2017
    • Apr 24, 2017: Purdue Pharma Names Josie Martin Head of Corporate Affairs & Communications
    • Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board
    • Apr 21, 2017: Purdue Pharma Announces Hire of Carrie Chomiak to Lead Over-the- Counter Franchise
    • Apr 19, 2017: FDA Meeting Confirms Development Policy for MRX-1OXT
    • Apr 10, 2017: Allergan Receives 2017 ENERGY STAR Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency
    • Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook
    • Apr 06, 2017: Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy
    • Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students
    • Apr 03, 2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch
    • Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors
    • Mar 31, 2017: Camurus appoints VP Corporate Development & General Counsel
    • Mar 30, 2017: Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility
    • Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers
    • Mar 24, 2017: UCB General Meeting on 27 April 2017
    • Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology
    • Mar 21, 2017: Recipharm partners with Sato to manufacture product for Japanese market
    • Mar 20, 2017: Corium Reports Positive Progress in Pilot Bioequivalence Study of Once- Weekly Corplex Donepezil Patch
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report